Liver exerkine reverses aging- and Alzheimer’s-related memory loss via vasculature
TL;DR
This discovery could lead to new treatments for age-related memory loss and Alzheimer's disease that don't require physical exercise. Instead of just telling people to exercise more, doctors might eventually be able to give patients the specific liver protein (GPLD1) or drugs that block TNAP to achieve the brain benefits of exercise. This is especially important for elderly or disabled people who cannot exercise regularly but still want to protect their memory and cognitive function.
Blood factors transfer the benefits of exercise to the aged brain independent of physical activity. Here, we show that the liver-derived exercise factor (exerkine) glycosylphosphatidylinositol (GPI)-specific phospholipase D1 (GPLD1), a GPI-degrading enzyme, reverses aging- and Alzheimer's-related memory loss by targeting the brain vasculature. GPLD1 has the potential to cleave over 100 putative GPI-anchored proteins, necessitating the identification of downstream targets that mediate cognitive rejuvenation for translational application. We identified GPI-anchored tissue-nonspecific alkaline phosphatase (TNAP) on the brain vasculature as a GPLD1 substrate. Mimicking age-related increases in cerebrovascular TNAP impaired blood-brain transport and cognition in young mice and mitigated GPLD1-induced cognitive benefits in aged mice. Inhibiting TNAP recapitulated the benefits of GPLD1 in old age, restoring youthful hippocampal transcriptional signatures and rescuing cognition. In an Alzheimer's disease model, increasing GPLD1 or inhibiting TNAP ameliorated Aβ pathology and improved cognitive deficits. We thus identify brain vasculature as a mediator of the cognitive benefits of a liver-to-brain exercise axis.
- 1Exercise triggers the liver to release GPLD1, a protein that can improve memory and cognition without requiring physical activity
- 2GPLD1 works by targeting a specific protein called TNAP on brain blood vessels that becomes problematic with age
- 3When TNAP levels increase with aging, it impairs the blood-brain barrier and hurts memory function
- 4Both increasing GPLD1 and directly blocking TNAP can restore youthful brain gene activity and rescue memory in aged mice
- 5In Alzheimer's disease models, this liver-to-brain pathway reduced harmful protein buildup and improved cognitive problems
Adversarial AI reveals mechanisms and treatments for disorders of consciousness
Imagine your brain is like a city with millions of roads and traffic systems. When you're awake and conscious, traffic flows in complex, coordinated patterns. In a coma, something has gone wrong — but we've never had a great way to figure out exactly which roads are broken or how to fix them. This study built a very smart AI that learned to tell the difference between 'awake brain' and 'coma brain' by studying hundreds of thousands of brainwave recordings. Then, like a detective, the AI was pitted against a simulated model of the brain to figure out: what changes in the brain's wiring would explain the difference? The AI figured out — on its own, without being told — that two key things go wrong in a coma: a specific circuit deep in the brain (called the basal ganglia indirect pathway) gets disrupted, and the brain's 'braking system' (inhibitory neurons) starts working too hard in the wrong places. The researchers then checked these predictions against real patient data, and both checked out. The AI also suggested that zapping a specific deep brain region with high-frequency electrical pulses might help wake people up — and early evidence from human patients supports this idea.
Gene conversion empowers natural selection in a clonal fish species
Unfortunately, the content of this research abstract could not be accessed due to paywall restrictions. Without being able to read the actual findings about gene conversion in clonal fish species, I cannot provide an accurate explanation of what the researchers discovered or why it matters.
Direct detection of an asteroid’s heliocentric deflection: The Didymos system after DART
NASA crashed a spacecraft into an asteroid moon called Dimorphos in 2022, and scientists have now measured that this impact actually nudged the entire asteroid system slightly off its path around the Sun. This is the first time humans have measurably changed how a celestial body orbits the Sun, proving that we can potentially deflect dangerous asteroids heading toward Earth.
The dynamics of AMPA receptors underlies the efficacy of ketamine in treatment resistant patients with depression
Think of your brain as having billions of tiny locks and keys. One particular lock — called the AMPA receptor — sits on brain cells and helps them talk to each other using the chemical glutamate. In people with hard-to-treat depression, this study found that those locks are less plentiful than normal, especially in emotional brain regions. When doctors gave these patients ketamine, it actually changed how many of those locks were available on the cell surface — and the bigger that change was, the better the patient felt. So ketamine isn't just temporarily numbing pain; it appears to be physically restoring a broken communication system in the brain. The scientists confirmed this by using a special brain scan (PET scan) with a radioactive tracer that literally glows where those AMPA receptor locks are located, letting them count them in real time in living people.